Brian D. Spund

Submitted by Anonymous (not verified) on
Full Name
Brian D. Spund
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Spund_Brian_D._MD_11121354.jpg
Type
Provider
Faculty
First Name
Brian
Last Name
Spund
NPI
1629377320
Faculty ID
15059
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-medicine
Gender
Male
Email
bspund@montefiore.org
Phone
718-920-5057
Titles
Type
Academic
Department
Department of Medicine
Department Link
Rank
Assistant Professor
Division
Hospital Medicine
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798833 40.8799447)
Address Line 1
Montefiore Medical Center
Address Line 3
111 East 210th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
SUNY Downstate College of Medicine
Education Type Label
Residency
Education Institution
North Shore Long Island Jewish Health System
CHAM Provider
Off
Professional Title
M.D.
EMR ID
68828
Is Open Scheduling
Off

Vance La Baron Smith

Submitted by Anonymous (not verified) on
Full Name
Vance La Baron Smith
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Smith_Vance_MD_420x504.jpg
Type
Provider
Faculty
First Name
Vance
Last Name
Smith
NPI
1942414511
Faculty ID
14416
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-surgery
Gender
Male
Email
vsmith@montefiore.org
Phone
718-920-4805
Titles
Type
Academic
Department
Department of Surgery
Rank
Associate Professor
Type
Clinical
Title
Director, Acute Care Surgery, Moses Campus
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.87862 40.88032)
Address Line 1
3400 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467-240
Location Title
Montefiore Greene Medical Arts Pavilion
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8785732 40.879979)
Address Line 1
Montefiore Medical Center
Address Line 2
Medical Arts Pavilion
Address Line 3
3400 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Medical College of Ohio
Education Type Label
Fellowship
Education Institution
Stanford University Medical Center
Education Type Label
Residency
Education Institution
Ohio State University Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
5833
Is Open Scheduling
Off

Sumeet Singh-Tan

Submitted by Anonymous (not verified) on
Full Name
Sumeet Singh-Tan
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/d41fe610-497e-11ec-8149-d1681d4b2362.jpg
Type
Provider
Faculty
First Name
Sumeet
Last Name
Singh-Tan
NPI
1215318001
Faculty ID
16569
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-medicine
Gender
Female
Email
ssinght@montefiore.org
Phone
718-920-5057
Titles
Type
Academic
Department
Department of Medicine
Department Link
Rank
Assistant Professor
Division
Hospital Medicine
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798833 40.8799447)
Address Line 1
Montefiore Medical Center
Address Line 3
111 East 210th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
A.T. Still University, Arizona School of Health Sciences
Education Type Label
Residency
Education Institution
Rush University Medical Center
CHAM Provider
Off
Professional Title
D.O.
EMR ID
14316
Is Open Scheduling
Off

Yang Shi

Submitted by Anonymous (not verified) on
Full Name
Yang Shi
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/Shi_Yang_MD_2x.jpg
Type
Provider
Faculty
First Name
Yang
Last Name
Shi
NPI
1962714261
Faculty ID
14864
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-pathology
Gender
Female
Email
yash@montefiore.org
Phone
718-920-6006
Titles
Type
Academic
Department
Department of Pathology
Department Link
Rank
Associate Professor
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798833 40.8799447)
Building
Central Building
Room
410-B
Address Line 1
Montefiore Medical Center
Address Line 3
111 East 210th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
China Medical University
Education Type Label
Fellowship
Education Institution
Cleveland Clinic
Education Type Label
Residency
Education Institution
University of California Irvine Medical Center
Education Type Label
Residency
Education Institution
China Medical University
Education Type Label
Residency
Education Institution
Duke University Medical Center
Research Areas
Studies molecular, cytogenetics, immunophenotypic, and morphologic findings of adult T-cell leukemia/lymphoma, plasmablastic lymphoma, HIV-related lymphoma and chronic myeloid leukemia.
CHAM Provider
Off
Professional Title
M.D.
Selected Publications

<ol>
<li>Jui Choudhuri, <strong><span style="text-decoration: underline;">Yang Shi</span></strong> (2019). Skin Nodules in a 40-year-old Caribbean Man: What Can We Learn about Adult T-cell Leukemia/Lymphoma in the United States? <strong>American Society for Clinical Pathology Case Reports. </strong>April 2019.</li>
<li>Etan Marks, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>(2018). Duodenal-type Follicular Lymphoma: A Clinicopathologic Review. <strong>Archives of Pathology &amp; Laboratory Medicine </strong>142 (4): 542-547.</li>
<li><strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Evan Kulbacki, Endi Wang (2018). Delayed diagnosis of Type B Niemann-Pick Disease in a 31-year-old Caucasian woman. <strong>Hematopathology.</strong>1-4</li>
<li>Evan Himchak, Etan Marks, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Yanhua Wang (2018). Did I miss it? Discovering Hidden Co-existing Hematological Neoplasms: A Single Institutional Review of 100 Collision Tumors. <strong>International Journal of Surgical Pathology.</strong> 26(4):296-305</li>
<li><strong><span style="text-decoration: underline;">Yang Shi</span></strong> (2018). Chronic myeloid leukemia blast phase with erythroid differentiation in a twenty-year-old male patient presented with hematemesis. <strong>American Society for Clinical Pathology Case Reports. </strong>April 2018.</li>
<li>Etan Marks, Yanhua Wang, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Joseph Susa, Mark Jacobson, D. Yitzchak Goldstein (2018). Specific TCR Gene Rearrangements in Mycosis Fungoides: Does Advanced Clinical Stage Show A Preference? <strong>Journal of Clinical Pathology.</strong> 2018;71:1072-1077</li>
<li>Urvi Shah, Sengotuvel Viswanathan, Beamon Agarwal, Aditi Shastri, Ioannis Mantzaris, Murali Janakiram, Noah Kornblum, Ira Braunschweig, Amit K. Verma, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>, John F. Reinus, Olga Derman (2018). Sinusoidal-Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure. <strong>Case Reports in Oncological Medicine, </strong>Published online&nbsp;Dec 3, 2018&nbsp;</li>
<li>Etan Marks, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Yanhua Wang (2017). CD117 (KIT) is a Useful Marker in The Diagnosis of Plasmablastic Plasma Cell Myeloma. <strong>Histopathology.</strong> 71(1):81-88.</li>
<li>Zhonghua Li, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>, John&nbsp;G.&nbsp;Pizzolo, and Yanhua Wang (2017). Utilization of Cytospin Slides in Flow Cytometry Laboratory: A Tool for Correlation of Morphology and Immunophenotype. <strong>Journal of Hematopathology.</strong> 10(2): 55-63.</li>
<li><strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Xiaoxian Zhao, Lisa Durkin, Heesun Joyce Rogers, Eric D Hsi (2016). Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. <strong>Human Pathology.</strong> 52:173-8</li>
<li><strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Andrew J Rand, Jennifer H Crow, Joseph O Moore, Anand S Lagoo (2015). Blast phase in chronic myelogenous leukemia (CML) is skewed towards unusual blast types in patients treated with tyrosine kinase inhibitors (TKIs): a comparative study of 67 cases.&nbsp; <strong>American Journal of Clinical Pathology. </strong>143(1):105-19.&nbsp;</li>
<li><strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Endi Wang (2014). Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.&nbsp; <strong>Archives of Pathology &amp; Laboratory Medicine</strong>. 138(4):564-9.</li>
<li><span style="text-decoration: underline;"><strong>Yang Shi</strong></span>, Endi Wang (2015). Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review with an Emphasis on Diagnostic Differentiation from Other T-Cell/Natural Killer-Cell Neoplasms.&nbsp; Archives of Pathology &amp; Laboratory Medicine.&nbsp; 139(9):1173-80.&nbsp;</li>
<li>Miglena Komforti, <strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Maggie Stocker, Endi Wang (2014). Suspicious mammographic masses in the breast of a 65-year-old female: Splenosis in an unusual body site due to a remote ballistic trauma. <strong>British Journal of Haematology</strong>. 167(2):148</li>
<li><strong><span style="text-decoration: underline;">Yang Shi</span></strong>, Evan Kulbacki, David H.K. Chui, Endi Wang (2013). Gigantic splenomegaly in a 27-year-old male of South-East Asian descent with concurrent diagnosis of myeloproliferative neoplasm and hemoglobin H disease. <strong>European Journal of Haematology.</strong> 91(3):284-5.</li>
</ol>

EMR ID
77786
Is Open Scheduling
Off

Kenneth Shapiro

Submitted by Anonymous (not verified) on
Full Name
Kenneth Shapiro
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/34c2e470-6f18-11ee-9e09-8d281394143a.jpg
Type
Provider
Faculty
First Name
Kenneth
Last Name
Shapiro
NPI
1700854486
Faculty ID
15555
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-surgery
Gender
Male
Email
kshapiro@montefiore.org
Phone
718-904-1400
Titles
Type
Academic
Department
Department of Surgery
Rank
Assistant Professor
Type
Clinical
Title
Assistant Professor of Surgery
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84849 40.84667)
Address Line 1
1578 Williamsbridge Road
City
Bronx
State
NY
Zip
10461-6265
Location Title
Montefiore at 1578 Williamsbridge
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8483118 40.8468944)
Address Line 1
Montefiore Medical Center
Address Line 2
1578 Williamsbridge Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York Medical College
Education Type Label
Fellowship
Education Institution
Staten Island University Hospital
Education Type Label
Residency
Education Institution
Cabrini Medical Center
CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

Dr. Shapiro&rsquo;s clinical focus is on hernia repairs and the gastrointestinal tract, utilizing state-of-the-art minimally invasive surgery techniques to provide optimal care.&nbsp;

Research Focus

Dr. Shapiro&rsquo;s research focuses on hernia repair.&nbsp;

EMR ID
4685
Biography

<p>Kenneth Shapiro, MD, FACS, is an attending surgeon and Assistant Professor, Surgery at Montefiore Einstein. Dr. Shapiro&rsquo;s clinical focus is on hernia repairs and the gastrointestinal tract, utilizing state-of-the-art minimally invasive surgery techniques to provide optimal care. He is proud to have served the Bronx community for his entire career.</p><p>In 1994, Dr. Shapiro graduated from The Sophie Davis School of Biomedicine, receiving his Bachelor of Science in biomedicine. He later attended New York Medical College, earning his Doctor of Medicine in 1996. After several months of clinical research with the Mount Sinai/Cabrini program, Dr. Shapiro pursued his surgery residency at Cabrini Medical Center, completing it in 2002. In 2003, he completed his minimally invasive surgery fellowship at Staten Island University.</p><p>Dr. Shapiro&rsquo;s research focuses on hernia repair. He has shared his work through publication in peer-reviewed journals and oral and poster presentations.</p><p>Dr. Shapiro is board certified by the American Board of Surgeons. He is a Fellow of the American College of Surgeons and a member of several professional organizations including the Society for Surgery of the Alimentary Tract and the Society of Laparoscopic Surgeons.</p>

Is Open Scheduling
Off

Natalie Semenyuk

Submitted by Anonymous (not verified) on
Full Name
Natalie Semenyuk
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg
Type
Provider
Faculty
First Name
Natalie
Last Name
Semenyuk
NPI
1841232642
Faculty ID
16159
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Female
Email
nsemenyuk@montefiore.org
Phone
718-920-5157
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
Minimally Invasive Gynecologic Surgery
Locations
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.80109 41.01639)
Address Line 1
141 South Central Avenue
City
Hartsdale
State
NY
Zip
10530
Location Title
Montefiore At 141 South Central Avenue
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798545 40.879242)
Room
1A
Address Line 1
Montefiore Medical Center
Address Line 3
3332 Rochambeau Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Univerzitet U Skopje Medicinski Fakultet
Education Type Label
Residency
Education Institution
Catholic Medical Center
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
111137
Is Open Scheduling
Off

Jonathan M. Schwartz

Submitted by Anonymous (not verified) on
Full Name
Jonathan M. Schwartz
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/Schwartz_Jonathan_MD_2x.jpg
Type
Provider
Faculty
First Name
Jonathan
Last Name
Schwartz
NPI
1215945738
Faculty ID
648
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-medicine
Gender
Male
Email
jonschwa@montefiore.org
Phone
914-849-3746
Titles
Type
Academic
Department
Department of Medicine
Department Link
Rank
Professor
Tags
me-patientcare-transplant-programs-liver
me-patientcare-transplant-team
Division
Hepatology
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.76846 41.02721)
Address Line 1
2 Longview Avenue, Suite 500
City
White Plains
State
NY
Zip
10601
Location Title
WPH Center for Cancer Care
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84607 40.84531)
Address Line 1
1521 jarrett Place
City
Bronx
State
NY
Zip
10461-2606
Location Title
Montefiore M-E Center for Cancer Care
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84544 40.84518)
Address Line 1
1621 Eastchester Road
City
Bronx
State
NY
Zip
10461-2301
Location Title
Montefiore Medical Group-Comprehensive Family Care Center (CFCC)
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.7689872 41.0260355)
Address Line 1
White Plains Hospital
Address Line 3
2 Longview Avenue
City
White Plains
State
NY
Zip
10601
Location Title
White Plains Hospital
Education and Trainings
Education Type Label
Medical Education
Education Institution
Sackler School of Medicine, Tel Aviv University
Education Type Label
Fellowship
Education Institution
University of Washington Med Center
Education Type Label
Residency
Education Institution
Jacobi Medical Center
Professional Interests

<p>Jonathan M. Schwartz is a board Certified Transplant Hepatologist. &nbsp;He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle. &nbsp;He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University.</p>
<p>Dr. &nbsp;Schwartz has an interest in treating patients with acute and chronic liver diseases including those patients with advanced liver diseases who require liver transplantation.</p>
<p>He has a special interest in the multidisciplinary care of patients with liver tumors.</p>

CHAM Provider
Off
Professional Title
M.D.
Selected Publications

<p><strong><br /></strong></p>
<ul>
<li>Estes JD, Stolpman D, Olyaei A, Ham JM, <strong>Schwartz JM</strong>, Orloff SL.&nbsp; High Prevalence of Potentially Hepatotoxic Herbal Supplement Use in Fulminant Hepatic Failure Patients. Arch Surg. 2003;138(8):852-8.</li>
<li><strong>Schwartz JM</strong>, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman D, Kowdley KV.&nbsp; Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts: Role of Increased Pulmonary Artery Pressure. J Clin Gastroenterol 2004;38(7):590-594.</li>
<li>Lim LL, Scarborough J, Thorne J, Graham E, Kempen J, Mackensen F, Nguyen Q D, Prabriputaloong T, Read R, Suhler EB, <strong>Schwartz JM</strong>, &nbsp;Smith JR. Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009;147(2):332-338.</li>
<li>O&rsquo;Glasser AY, Scott DA, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, and <strong>Schwartz JM.</strong>Hepatic and Cardiac Iron Overload Among Patients with End-Stage Liver Disease Referred for Liver Transplantation. Clinical Transplantation. Clin Transplant. 2010 Sep-Oct;24(5):643-51.</li>
<li>Kanwal F, Befeler A, Chari R, Marrero J, Kahn J, Afdhal N, Morgan T, Roberts L, Mohanty SR, <strong>Schwartz J</strong>, Van Thiel D, Hassanein TI, Li J, Zeringue A, DiBisceglie A. Rate of Potentially Curative Treatment in Patients with Hepatocellular Carcinoma.&nbsp; Aliment Pharmacol Ther. 2012 Aug;36(3):257-65.</li>
<li>Bichoupan K1,&nbsp;<strong>Schwartz JM,</strong>&nbsp;Martel-Laferriere V,&nbsp;Giannattasio ER,&nbsp;Marfo K,&nbsp;Odin JA,&nbsp;Liu LU,&nbsp;Schiano TD,&nbsp;Perumalswami P,&nbsp;Bansal M,&nbsp;Gaglio PJ,&nbsp;Kalia H,Dieterich DT,&nbsp;Branch AD,&nbsp;Reinus JF. Effect of Fibrosis on Adverse Events in Patients with Hepatitis C Treated with Telaprevir. Aliment Pharmacol Ther.&nbsp;2014;39(2):209-16.</li>
<li><strong>Schwartz J</strong> and Carithers RL.&nbsp; Epidemiology and Etiologic Associations of Primary Hepatocellular Carcinoma.&nbsp; In Rose BD, editor. Up to date in Gastroenterology and Hepatology.&nbsp; Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li><strong>Schwartz JM </strong>and Carithers RL, Jr.&nbsp; Clinical features, diagnosis, and screening for primary hepatocellular carcinoma.&nbsp; Up to date in Gastroenterology and Hepatology.&nbsp; Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Curley SA, Stewart KE, <strong>Schwartz JM</strong>, Carthers RL, Jr.&nbsp; Nonsurgical therapies for localized hepatocellular carcinoma.&nbsp; Up to date, Inc. Wellesley, MA, Updated 2014.<strong>&nbsp;</strong></li>
<li><strong>Schwartz JM</strong>.&nbsp; Approach to the patient with a focal liver lesion.&nbsp; Up to date Inc Gastroenterology and Hepatology.&nbsp; Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Hartwell L and <strong>Schwartz JM.&nbsp; </strong>AsymptomaticLiver Chemistry Abnormalities. Journal of Clinical Outcomes Management. 2009; 16 (11): 525-34.</li>
<li>Urquhart J<strong>, Schwartz, JM.</strong> Hepatocellular Carcinoma Surveillance in a Western Population with Hepatitis B. Current Hepatitis Reports, 2011.</li>
<li><strong>Schwartz, JM </strong>and Reinus JF.&nbsp; Prevalence and Natural History of Alcoholic Liver Disease.&nbsp; Clinics in Liver Disease. 2012; 16 (4): 659-66.</li>
</ul>
<p>&nbsp;</p>

EMR ID
3842
Is Open Scheduling
Off

Scott J. Schafler

Submitted by Anonymous (not verified) on
Full Name
Scott J. Schafler
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/Scott-Schafler.jpg
Type
Provider
Faculty
First Name
Scott
Last Name
Schafler
NPI
1417219585
Faculty ID
16440
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-medicine
Gender
Male
Email
sschafle@montefiore.org
Phone
718-920-3776
Titles
Type
Academic
Department
Department of Medicine
Department Link
Rank
Assistant Professor
Division
Hospital Medicine
Type
Administrative
Locations
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.845 40.85026)
Address Line 1
1825 Eastchester Road
City
Bronx
State
NY
Zip
10467-2404
Location Title
Montefiore Weiler Hospital
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88059 40.87818)
Address Line 1
3317 Rochambeau Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore at 3317 Rochambeau Avenue
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.82894 41.05873)
Address Line 1
555 Taxter Road
City
Elmsford
State
NY
Zip
10523
Location Title
Montefiore at 555 Taxter Road
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798833 40.8799447)
Room
652
Address Line 1
Montefiore Medical Center
Address Line 3
111 East 210th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Robert Wood Johnson Medical School
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
55639
Is Open Scheduling
Off

Alexander I. Sankin

Submitted by Anonymous (not verified) on
Full Name
Alexander I. Sankin
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/6a135040-3a87-11ed-8158-59ecbd24247c.jpg
Type
Provider
Faculty
Expert
First Name
Alexander
Last Name
Sankin
NPI
1982866570
Faculty ID
14891
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Gender
Male
Email
asankin@montefiore.org
Phone
347-842-1700
Titles
Type
Academic
Type
Clinical
Title
Attending Physician
Tags
me-patientcare-cancer-research-therapeutics
Type
Clinical
Title
Associate Professor, Urology
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84154 40.84612)
Address Line 1
1250 Waters place
City
Bronx
State
NY
Zip
10461-2720
Location Title
Montefiore at 1250 Waters Place
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.839137 40.8526781)
Building
Tower 1
Room
PH
Address Line 1
Montefiore Medical Center
Address Line 3
1250 Waters Place
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Fellowship
Education Institution
Memorial Sloan Kettering Cancer Center
Education Type Label
Residency
Education Institution
SUNY Downstate
Professional Interests

<p>Dr. Sankin is an academic surgeon in the Department of Urology, at Montefiore Medical Center with a clinical focus on surgical approaches to the management of urologic malignancies of the upper urinary tract and bladder. His academic focus is divided between clinical and translational research studying emerging treatments and techniques central to the surgical care of patients with urologic cancers.&nbsp;</p>
<p>Dr. Sankin is the site-Principal Investigator for multiple clinical trials studying novel therapeutics for patients with bladder cancer who wish to avoid radical cystectomy. As an active member of multiple clinical trial consortiums including Eastern Cooperative Oncology Group and the Society of Urologic Oncology Clinical Trials Consortium, Dr. Sankin speardeaded the development of a bladder cancer clinical trials program at Einstein.&nbsp;</p>
<p>His translational research focuses on characterizing the tumor immune microenvironment of bladder tumors and the role of novel checkpoint molecules as relevant therpeutic targets. &nbsp;</p>
<p>&nbsp;</p>

Research Areas
Bladder preserving treatment options in patients with high risk bladder cancer, development of new immunotherapies for bladder cancer.
Expert Tags
Areas of Expertise
Urological malignancies
Prostate
Testicular
Bladder Carcinoma
Expert Summary

<p>Dr. Sankin current research program focuses on the translational application of immune-oncology to the treatment of urologic cancer.</p>

CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

Dr. Sankin's&nbsp;clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Building on his clinical focus, Dr. Sankin&rsquo;s research centers on bladder-preserving treatment options in patients with high-risk bladder cancer and the development of new immunotherapies for bladder cancer.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Selected Publications

<p align="left">Clark TW,&nbsp;Sankin A, Becske T, Nelson PK, Fox M.&nbsp;&nbsp;Stent-assisted Gugliemi detachable coil repair of wide-necked renal artery aneurysm using 3-D angiography.&nbsp;&nbsp;Vasc Endovascular Surg 2008 Jan; 41(6):528-32</p>
<p align="left">Tareen B,&nbsp;Sankin A, Godoy G, Temkin S, Lepor H, Taneja SS.&nbsp;Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort<em>.</em>&nbsp;Urology.&nbsp;&nbsp;2009 Feb;73(2):351-4</p>
<p align="left">Tareen B, Godoy G,&nbsp;Sankin A, Temkin S, Lepor H, Taneja SS.&nbsp;&nbsp;Laterality alone should not drive selection of candidates for hemi-ablative focal therapy.&nbsp;J Urol.&nbsp;&nbsp;2009 Mar;181(3):1082-9</p>
<p align="left">Tareen B, Godoy G,&nbsp;Sankin A, Temkin S, Lepor H, Taneja SS.&nbsp;&nbsp;Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?&nbsp;&nbsp;BJU Int. 2009 Jul;104(2):195-9</p>
<p align="left">Marien T,&nbsp;Sankin A, Lepor H.&nbsp;&nbsp;Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy.&nbsp;&nbsp;J Urol.&nbsp;&nbsp;2009 Apr;181(4):1817-22</p>
<p align="left">Sankin A, Tareen B, Lepor H.&nbsp;&nbsp;Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.&nbsp;&nbsp;Prostate Cancer Prostatic Dis.&nbsp;&nbsp;2009;12(2):204-8</p>
<p align="left">Mufarrij P,&nbsp;Sankin A, Godoy G, Lepor H.&nbsp;Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy.&nbsp;&nbsp;Urology.&nbsp;&nbsp;2010 Sep;76(3):689-92</p>
<p align="left">Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N.&nbsp;&nbsp;Rate of renal cell carcinoma subtypes in different races.&nbsp;&nbsp;Int Braz J Urol.&nbsp;&nbsp;2011 Feb;37(1):29-32</p>
<p align="left">Sankin A, Sfakianos J, Schiff J, Sjoberg D, Coleman J.&nbsp;Assessing renal function following partial nephrectomy using renal nuclear scintigraphy and eGFR.&nbsp;&nbsp;Urology.&nbsp;&nbsp;2012 Aug;80(2):343-6</p>
<p align="left">Ghavamian R, Hakimi AA, Williams SK, Kim PH, Chen L, Sfakianos JP, Keren-Paz GE,&nbsp;Sankin A,&nbsp;Ginzburg N, Coleman JA.&nbsp;&nbsp;Factors affecting proportional glomerular filtration rate following minimally invasive partial nephrectomy.&nbsp;&nbsp;J Endourology&nbsp;&nbsp;2013 Nov;27(11):1371-5</p>
<p align="left">Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ.&nbsp;&nbsp;The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.&nbsp;&nbsp;Cancer Medicine 2014 Dec;3(6):1485-92</p>
<p align="left">Mano R, Vertosick E,&nbsp;Sankin A,&nbsp;Chevinsky M, Larish Y, Jakubowski CD, Hotker AM, Sjoberg D, Akin O, Russo P.&nbsp;&nbsp;The clinical significance of indeterminate pulmonary nodules in patients with renal cell carcinoma.&nbsp;&nbsp;J Urol 2014 Mar;193(3):776-82</p>
<p align="left">Chevinsky M, Imnadze M,&nbsp;Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen YB, Tickoo SK, Reuter VE, Hakimi AA, Russo P.&nbsp;Pathologic stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma.&nbsp;J Urol 2015 Aug;194(2):310-5</p>
<p align="left">Hakimi AA, Tickoo S, Jacobsen A, Sarungbam J, Sfakianos J, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Chen YB,&nbsp;Sankin A,&nbsp;Mano R, Coleman JA, Russo P, Ogawa S, Sander C, Hsieh JJ, Reuter VE.&nbsp;TCEB1-mutated renal cell carcinoma: a distinct genomic and morphologic subtype.&nbsp;&nbsp;Mod Pathol 2015 June;28(6):845-53</p>
<p align="left">Sankin A,&nbsp;Hakimi AA, Hsieh JJ, Molina AM.&nbsp;&nbsp;Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies.&nbsp;&nbsp;Front Oncol 2015 Apr 8;5:67</p>
<p align="left">Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, Winer AG, Mano R,&nbsp;Sankin A, Motzer RJ, Voss MH, Offit K, Purdue M, Pomerantz M, Freedman M, Choueiri TK, Hsieh JJ, Klein RJ.&nbsp;&nbsp;Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell&nbsp;carcinoma.&nbsp;&nbsp;Cancer 2016 Feb 1;122(3):402-10</p>
<p align="left">Sankin A. Discovering biomarkers within the genomic landscape of renal cell carcinoma.&nbsp;&nbsp;J Kidney 2016 Feb 2(1)&nbsp;</p>
<p align="left">Sankin A, Tin A, Mano R, Chevinsky M, Jakubowski C, Cha E, Yee A, Friedman F, Sjoberg D, Ehdaie B, Coleman J.&nbsp;&nbsp;Impact of ureteroscopy prior to nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes.&nbsp;&nbsp;Urology 2016 Aug; 94:148-53</p>
<p align="left">Mano R, Hakimi AA,&nbsp;Sankin AI,&nbsp;Sternberg IA, Chevinsky MS, Russo P.&nbsp;&nbsp;Surgical treatment of tumors involving kidneys with fusion anomalies &ndash; a contemporary series.&nbsp;&nbsp;Urology 2016 Aug; 98:97-102</p>
<p align="left">Zhou TC,&nbsp;Sankin A,&nbsp;Porcelli SA, Perlin DS, Schoenberg MP, Zang XX.&nbsp;&nbsp;A review of the PD-1/PD-L1 checkpoint in bladder cancer: from mediator of immune escape, to target for treatment.&nbsp;&nbsp;Urol Oncol 2017 Jan;35(1):14-20&nbsp;</p>
<p align="left">Winer AG, Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD,&nbsp;Sankin AI,&nbsp;Sfakianos JP, Cha EK, Dalbagni G, Coleman JA.&nbsp;Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.&nbsp;&nbsp;Urol Oncol 2017 April;35(4):151</p>
<p align="left">Sankin&nbsp;A,&nbsp;Narasimhulu&nbsp;D, John P,&nbsp;Gartrell&nbsp;B, Schoenberg M, Zang XX.&nbsp; The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: what lies beneath the tip of the iceberg, PD-L1.&nbsp;&nbsp;Urol&nbsp;Onc&nbsp;2017 (Epub ahead of print)</p>
<p align="left">Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T,&nbsp;Sankin A,&nbsp;Pierorazio PM, Schoenberg MP, Bivalacqua TJ. Oncological outcomes of sequential intravesical gemcitabine and docetaxel in patients with non-muscle invasive bladder cancer.&nbsp;&nbsp;Bladder Cancer 2017 Oct 27;3(4):293-303</p>
<p align="left">Daneshmand S, Patel s, Lotan Y, Pohar K, Trabulsi E, Woods M, Downs T, Huang W, Jones J, O&rsquo;Donnell M, Bivalacqua T, DeCastro J, Steinberg G, Kamat A, Resnick M, Konety B, Schoenberg M, Jones JS,&nbsp;Flexible Blue Light Study Group Collaborators.&nbsp;Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.&nbsp;&nbsp;J Urol 2018 May;199(5):1158-65</p>
<p align="left">Fridman D, Abeshouse M,&nbsp;Sankin A.&nbsp;Paraurethral Leiomyoma as an Incidental Finding in a Patient with Fibroid Uterus. Case Rep Obstet Gynecol 2018 Feb 7;2018</p>
<p align="left">Adrianzen Hererra DA, Goldberg-Stein S,&nbsp;Sankin A, Sarungbam J, Sharma J, Gartrell BA. Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies. Front Oncol, 2018 Apr 30;8:137</p>
<p align="left">Berstein A, Fram EB,&nbsp;Sankin A, Kovac E, Srivastava A, DiVito J, Stern JM. A Comparison of Perinephric Fat Surface Area and Mayo Adhesive Probability Score in Predicting Malignancy in T1 Renal Masses.&nbsp;&nbsp;Urol Onc 2018 Nov; 36(11):499</p>
<p align="left">Sun Y, Reuter VE, Magi-Galluzzi C,&nbsp;Sankin A,&nbsp;Epstein JI.&nbsp;Granular Cell Tumor of the Bladder: A Report of Six Cases.&nbsp;&nbsp;Urology 2018 Nov; 121:203&nbsp;</p>
<p align="left">Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ,&nbsp;Sankin A,&nbsp;Schoenberg MP, Shipley WU, Villers A, Efstathiou J, Bellmunt J, Stenzl A.&nbsp;&nbsp;Recommendations From Joint SIU-ICUD Consultation On Bladder Cancer: Muscle-Invasive Presumably Regional Tumor.&nbsp;&nbsp;World J Urol 2019, Jan;37(1): 61-83</p>
<p align="left">Chand D, Dhawan D,&nbsp;Sankin A, Ren X, Lin J, Schoenberg M, Knapp DW, Zang X. Immune checkpoint B7x (B7-H4/B7S1/VtCN1) is overexpressed in spontaneous canine bladder cancer: the first report and its implications in a preclinical model. Bladder Cancer 2019, Jan 31;5(1)63-71</p>
<p align="left">Bernstein A, Barry E, Fram EB,&nbsp;Sankin A,&nbsp;Kovac E, Stern JM.&nbsp;Does Glomerular Filtration Rate at Discharge After Partial Nephrectomy Predict Long-Term Glomwerular Filtration Rate Stability?. J Endourol 2019, Jun;33(6):488-491</p>
<p align="left">Lotan Y, Bivalacqua TJ, Downs T, Huang W, Jones J, Kamat A, Konety B, Malmstrom PU, McKiernan J, O&rsquo;Donnell M, Patel S, Pohar K, Resnick M,&nbsp;Sankin A,&nbsp;Smith A, Steinberg G, Trabulsi E, Woods M, Daneshmand S.&nbsp;&nbsp;Blue light flexible cystoscopy with hexaminolevulinate in non-muscle invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA &ndash; update 2018. Nat Rev Urol 2019, Jun;16(6):377-386</p>
<p align="left">Sankin A,&nbsp;Chand D, Schoenberg M, Zang X.&nbsp;&nbsp;Human urothelial bladder cancer generates a clonal immune response: the results of T-cell receptor sequencing.&nbsp;&nbsp;Urol Oncol 2019, May 15 (epub ahead of print).</p>
<p align="left">Wang H, Kaur G,&nbsp;Sankin A,&nbsp;Chen F, Guan F, Zang X.&nbsp;Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.&nbsp;&nbsp;J Hematol Oncol 2019, Jun 11;12(1):59</p>
<p align="left">Daniels MJ, Barry E, Schoenberg M, Lamm DL, Bivalacqua TJ,&nbsp;Sankin A, Kates M.&nbsp;&nbsp;Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer. Urol Oncol 2019, Jun 26 (epub ahead of print)</p>
<p align="left">Daniels MJ, Barry E, Milbar N, Schoenberg M, Bivalacqua TJ,&nbsp;Sankin A, Kates M. An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle invasive bladder cancer.&nbsp;&nbsp;Urol Oncol 2019, Aug 28 (epub ahead of print)</p>
<p align="left">Khaki AR, Li A, Diamantopoulos LN, Bilen MA, Santos V, Esther J, Morales-Barrera R, Devitt M, Nelson A, Holmes CJ, Shreck E, Assi H, Gartrell BA, Sankin A,&nbsp;Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Baratam P, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P.&nbsp;&nbsp;Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors.&nbsp;&nbsp;Cancer 2019, Dec 12 (epub ahead of print)</p>

EMR ID
78143
Biography

<p>Alexander I. Sankin, MD, is Associate Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer.</p><p>After earning his Master of Science from the University of Pennsylvania in 2004, Dr. Sankin earned his Doctor of Medicine from New York University in 2008 and completed his residency in surgery and urology at the State University of New York Downstate in 2013. He then completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in 2015.</p><p>Building on his clinical focus, Dr. Sankin&rsquo;s research centers on bladder-preserving treatment options in patients with high-risk bladder cancer and the development of new immunotherapies for bladder cancer. He is the site-principal investigator for multiple clinical trials studying novel therapeutics for patients with bladder cancer who wish to avoid radical cystectomy. As an active member of multiple clinical trial consortiums, including Eastern Cooperative Oncology Group and the Society of Urologic Oncology Clinical Trials Consortium, Dr. Sankin spearheaded the development of a bladder cancer clinical trials program at Einstein. His translational research focuses on characterizing the tumor immune microenvironment of bladder tumors and the role of novel checkpoint molecules as relevant therapeutic targets. His work has been published in numerous peer-reviewed journals.</p><p>Dr. Sankin is board certified and a member of the American Urological Association and the Society of Urologic Oncology.</p>

Is Open Scheduling
Off

Ohad D. Rotenberg

Submitted by Anonymous (not verified) on
Full Name
Ohad D. Rotenberg
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/2e13dc30-c4aa-11eb-925b-439657343c68.jpg
Type
Provider
Faculty
First Name
Ohad
Last Name
Rotenberg
NPI
1770663338
Faculty ID
4113
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Male
Email
orotenbe@montefiore.org
Phone
718-920-5157
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Associate Professor
Division
Fetal Medicine & Ultrasound
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88022 40.87856)
Address Line 1
3332 Rochambeau Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Centennial
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8798545 40.879242)
Building
Centennial Building
Address Line 1
Montefiore Medical Center
Address Line 3
3332 Rochambeau Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Sackler School of Medicine, Tel Aviv University
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
3947
Is Open Scheduling
Off
Subscribe to Hernias